A comprehensive review in “Biofunct. Mater.” meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits of FDA-approved nanodrugs, and innovative approaches to address tumor heterogeneity and treatment resistance. This serves as a foundational framework and pragmatic guide for enhancing precision-based breast cancer therapies.
Breast cancer, the most common cancer among women worldwide, is a major therapeutic challenge because of its profound heterogeneity. Breast cancer can be classified into several molecular subtypes, such as Luminal A, HER2-positive, and triple-negative breast cancer (TNBC), and a treatment that is effective for one patient may not work for another. In addition to this intrinsic heterogeneity, drug resistance and serious side effects have prompted the pursuit of more accurate and precise therapeutic strategies.
Nanomedicine, utilizing engineered nanoparticles for targeted drug delivery to tumors, presents a promising avenue for future treatment strategies. However, the design of an appropriate nanocarrier for individual patients has historically been a complex and often inefficient process of trial and error. The multitude of potential design parameters, including size, surface charge, and targeting ligand density, leads to a combinatorial explosion that is not feasible to test experimentally.
In this review, researchers from Shanghai Jiao Tong University School of Medicine and Guangdong Medical University have proposed a novel, data-driven solution to address the aforementioned challenge. They introduce an “AI-multi-omics intelligent delivery paradigm,” in which a machine learning model is utilized to predict the optimal design of nanocarriers. This prediction is based on the unique biological signatures specific to a patient’s tumor.
We have transitioned from a universal, one-size-fits-all methodology to a subtype-specific, intelligent drug delivery system. Many studies demonstrate that the incorporation of multi-omics data with artificial intelligence can effectively simplify complex processes. For example, in the case of aggressive Luminal B tumors, our model significantly enhanced the synchronization between drug release and peak tumor proliferation rates, increasing it by a factor of 2.8 compared to traditional static nanocarriers.”
Meng-Yao Li, corresponding author
The review methodically delineates the manner in which this paradigm capitalizes on subtype-specific vulnerabilities. In the case of HER2-positive breast cancer, the utilization of trastuzumab-conjugated dendrimers resulted in a reduction of off-target toxicity by 47%. For the treatment of TNBC, a notoriously difficult-to-treat subtype, the employment of EGFR-antibody liposomes amplified tumor accumulation by a factor of 3.2.
The study also presents a comprehensive review of the current state of clinical nanomedicine, ranging from FDA-approved drugs such as Doxil®-which significantly decreases the cardiotoxicity of doxorubicin from 18% to 3%-to promising therapies currently under clinical trials. Notably, preliminary results for ²²⁵Ac-liposomes indicate that 77.8% of patients with metastatic TNBC achieved stable disease status for a duration of six months or longer, without any observed bone marrow toxicity.
“The potential is profound,” elucidates Yimao Wu, a co-first author of the review. “This transcends mere incremental advancements. It offers a viable roadmap to engineer health, morphing breast cancer from a perilous disease into a manageable condition via personalized nanotherapeutic intervention.”
The authors recognize that issues related to large-scale manufacturing and long-term safety continue to impede clinical adoption. Nevertheless, with the incorporation of AI, multi-omics data, and biomimetic nanocarriers such as exosomes, the trajectory of breast cancer treatment is on course to be notably more accurate and efficacious in the future.
This paper ‘Intelligent delivery and clinical transformation of nanomedicine in breast cancer: from basic research to individualized therapy’ was published in Biofunctional Materials (ISSN: 2959-0582), an online multidisciplinary open access journal aiming to provide a peer-reviewed forum for innovation, research and development related to bioactive materials, biomedical materials, bio-inspired materials, bio-fabrications and other bio-functional materials.
Wu, Y., et al. (2025) Intelligent delivery and clinical transformation of nanomedicine in breast cancer: from basic research to individualized therapy. Biofunctional Materials, https://doi.org/10.55092/bm20250014.
News
Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment
A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment. This paper presents an exhaustive overview of subtype-specific nanostrategies, the clinical benefits [...]
It’s Not “All in Your Head”: Scientists Develop Revolutionary Blood Test for Chronic Fatigue Syndrome
A 96% accurate blood test for ME/CFS could transform diagnosis and pave the way for future long COVID detection. Researchers from the University of East Anglia and Oxford Biodynamics have created a highly accurate [...]
How Far Can the Body Go? Scientists Find the Ultimate Limit of Human Endurance
Even the most elite endurance athletes can’t outrun biology. A new study finds that humans hit a metabolic ceiling at about 2.5 times their resting energy burn. When ultra-runners take on races that last [...]
World’s Rivers “Overdosing” on Human Antibiotics, Study Finds
Researchers estimate that approximately 8,500 tons of antibiotics enter river systems each year after passing through the human body and wastewater treatment processes. Rivers spanning millions of kilometers across the globe are contaminated with [...]
Yale Scientists Solve a Century-Old Brain Wave Mystery
Yale scientists traced gamma brain waves to thalamus-cortex interactions. The discovery could reveal how brain rhythms shape perception and disease. For more than a century, scientists have observed rhythmic waves of synchronized neuronal activity [...]
Can introducing peanuts early prevent allergies? Real-world data confirms it helps
New evidence from a large U.S. primary care network shows that early peanut introduction, endorsed in 2015 and 2017 guidelines, was followed by a marked decline in clinician-diagnosed peanut and overall food allergies among [...]
Nanoparticle blueprints reveal path to smarter medicines
Lipid nanoparticles (LNPs) are the delivery vehicles of modern medicine, carrying cancer drugs, gene therapies and vaccines into cells. Until recently, many scientists assumed that all LNPs followed more or less the same blueprint, [...]
How nanomedicine and AI are teaming up to tackle neurodegenerative diseases
When I first realized the scale of the challenge posed by neurodegenerative diseases, such as Alzheimer's, Parkinson's disease and amyotrophic lateral sclerosis (ALS), I felt simultaneously humbled and motivated. These disorders are not caused [...]
Self-Organizing Light Could Transform Computing and Communications
USC engineers have demonstrated a new kind of optical device that lets light organize its own route using the principles of thermodynamics. Instead of relying on switches or digital control, the light finds its own [...]
Groundbreaking New Way of Measuring Blood Pressure Could Save Thousands of Lives
A new method that improves the accuracy of interpreting blood pressure measurements taken at the ankle could be vital for individuals who are unable to have their blood pressure measured on the arm. A newly developed [...]
Scientist tackles key roadblock for AI in drug discovery
The drug development pipeline is a costly and lengthy process. Identifying high-quality "hit" compounds—those with high potency, selectivity, and favorable metabolic properties—at the earliest stages is important for reducing cost and accelerating the path [...]
Nanoplastics with environmental coatings can sneak past the skin’s defenses
Plastic is ubiquitous in the modern world, and it's notorious for taking a long time to completely break down in the environment - if it ever does. But even without breaking down completely, plastic [...]
Chernobyl scientists discover black fungus feeding on deadly radiation
It looks pretty sinister, but it might actually be incredibly helpful When reactor number four in Chernobyl exploded, it triggered the worst nuclear disaster in history, one which the surrounding area still has not [...]
Long COVID Is Taking A Silent Toll On Mental Health, Here’s What Experts Say
Months after recovering from COVID-19, many people continue to feel unwell. They speak of exhaustion that doesn’t fade, difficulty breathing, or an unsettling mental haze. What’s becoming increasingly clear is that recovery from the [...]
Study Delivers Cancer Drugs Directly to the Tumor Nucleus
A new peptide-based nanotube treatment sneaks chemo into drug-resistant cancer cells, providing a unique workaround to one of oncology’s toughest hurdles. CiQUS researchers have developed a novel molecular strategy that allows a chemotherapy drug to [...]
Scientists Begin $14.2 Million Project To Decode the Body’s “Hidden Sixth Sense”
An NIH-supported initiative seeks to unravel how the nervous system tracks and regulates the body’s internal organs. How does your brain recognize when it’s time to take a breath, when your blood pressure has [...]
